Cytokine and Body Composition's Changes in Overweight/Obese Women
1 other identifier
interventional
59
1 country
1
Brief Summary
Sincev the adipose tissue as been identified as a metabolic active tissue that produces and regulates pro-inflammatory factors, the investigators studied the relationship between cytokine changes and maternal body composition. The investigators evaluated plasmatic pro- and anti-inflammatory cytokines levels in pregnant women with BMI \>25 Kg/m\^2 undergoing a lifestyle change program, and if this is related with changes in body composition. Women enrolled in the study were provided nutritional advices about lifestyle: a proper nutrition and a constant physical activity (30 minutes/day, 3 times/week, according to the American College of Obstetricians and Gynecologists Guidelines) in an integrated counselling with a dietitian and a gynaecologist, both attendant since the enrollment. Plasma pro- and anti-inflammatory markers were investigated at enrollment (9-12 weeks) and at 36-38 weeks. Furthermore, the investigators used the bioimpedance analyzer to evaluate changes of body composition (i.e. fat mass and fat free mass) at first and third trimester.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 14, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedFirst Posted
Study publicly available on registry
May 9, 2016
CompletedMay 9, 2016
April 1, 2016
1.2 years
April 14, 2016
May 6, 2016
Conditions
Outcome Measures
Primary Outcomes (3)
Cytokine changes throughout pregnancy in overweight/obese women undergoing a lifestyle change program.
interferon(IFN)-γ, interleukin(IL)-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, and tumor necrosis factor-α plasma levels (pg/ml)
At baseline, at 36-38 week
Weight changes
Weight at baseline (i.e. enrollment: 9 weeks) and at 36 weeks measured in kg
At baseline, at 36 weeks
Fat mass changes
Changes in total and visceral (trunk) fat mass (FM) at baseline (i.e. enrollment: 9 weeks), at 36 weeks and calculated as fat changes
At baseline, at 36 weeks
Study Arms (1)
Lifestyle change intervention
OTHEROverweight/obese pregnant women enrolled in a healthy lifestyle change programm
Interventions
Women attended a multidisciplinary counseling (by both the dietitian and the gynecologist). They were given nutritional advice about lifestyle and physical activity, in agreement with the Italian Guidelines for a healthy diet during pregnancy. The diet given comprised 1500 kcal/day and consisted of 3 main meals and 3 snacks (breakfast, snack, lunch, snack, dinner, and evening snack) that corresponds to the baseline metabolism of a pregnant woman. In view of the physical activity program, the dietitian added an amount of 200 kcal/day for obese or 300 kcal/day for overweight women. The exercise intervention was focused on increasing walking and developing a more active lifestyle. The recommendation for physical activity was to perform 30 min of moderate intensity activity at least 3 days a week.
Eligibility Criteria
You may qualify if:
- age \>18 years
- single pregnancy
You may not qualify if:
- twin pregnancies
- chronic diseases (i.e., diabetes mellitus, chronic hypertension, untreated thyroid diseases)
- dietary supplements or herbal products known to affect body weight
- other medical conditions that might affect body weight
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mother-Infant Department, University of Modena and Reggio Emilia, Italy
Modena, 41124, Italy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chairman of Obstetrics and Gynecology Unit
Study Record Dates
First Submitted
April 14, 2016
First Posted
May 9, 2016
Study Start
January 1, 2015
Primary Completion
April 1, 2016
Study Completion
May 1, 2016
Last Updated
May 9, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share